Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer
- PMID: 31497297
- PMCID: PMC6719253
- DOI: 10.3892/mco.2019.1912
Pre-treatment psoas major volume is a predictor of poor prognosis for patients with epithelial ovarian cancer
Abstract
Low skeletal muscle mass (sarcopenia) is an important prognostic risk factor for the outcome of a variety of cancer types. The current study investigated whether skeletal muscle area (SMA), psoas area (PA) and psoas major volume (PV) are associated with progression-free survival (PFS) and overall survival (OS) in patients with epithelial ovarian cancer (OC). A total of 92 OC patients were enrolled in the present study. Pre-treatment with SMA and PA was assessed using computed tomography (CT) and PV was calculated using a three-dimensional-CT (3D-CT). The clinical factors associated with sarcopenia and prognosis were retrospectively evaluated. For all patients, the median PFS and OS were 19 and 32 months, respectively. Patients exhibiting lower PV (<195.6 cm3) had significantly poorer PFS and OS compared with patients exhibiting higher PV (≥195.6 cm3; P=0.018 and P=0.006), while those with low SMA (<92.92 cm2) had significantly worse OS than patients with higher SMA (≥92.92 cm2; P=0.030). PV was also demonstrated to be superior to SMA and PA in prognosis prediction. PV by 3D-CT can serve as an indicator of poor prognosis in patients with OC.
Keywords: low skeletal muscle mass; ovarian cancer; prognostic factor; psoas area; psoas major volume; skeletal muscle area.
Figures



References
-
- American Cancer Society. American Cancer Society; Atlanta, GA: 2009. Cancer Facts & Figures 2009.
-
- Vergote IB, Kaern J, Abeler VM, Pettersen EO, De Vos LN, Tropé CG. Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol. 1993;169:40–52. doi: 10.1016/0002-9378(93)90129-7. - DOI - PubMed
-
- Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–1547. doi: 10.1200/JCO.2012.45.2722. - DOI - PubMed
LinkOut - more resources
Full Text Sources